Radhika Nair Selected Research

Radhika Nair Research Topics

Disease

10	Neoplasms (Cancer) 07/2021 - 11/2010
9	Breast Neoplasms (Breast Cancer) 01/2020 - 08/2010
4	Neoplasm Metastasis (Metastasis) 07/2021 - 06/2011
3	Carcinogenesis 07/2021 - 03/2013
3	Carcinoma (Carcinomatosis) 01/2018 - 06/2011
2	Triple Negative Breast Neoplasms 01/2020 - 01/2020
1	COVID-19 01/2022
1	Stroke (Strokes) 01/2022
1	Cognitive Dysfunction 01/2021
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2021
1	Ovarian Neoplasms (Ovarian Cancer) 11/2020
1	Type 2 Diabetes Mellitus (MODY) 07/2020
1	Glaucoma 09/2019
1	Ocular Hypertension (Glaucoma, Suspect) 09/2019
1	Rheumatoid Arthritis 08/2019
1	Pain (Aches) 08/2019
1	Ischemic Stroke 11/2018
1	Lung Neoplasms (Lung Cancer) 06/2017
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 06/2017
1	Fibrosarcoma 01/2013
1	Coronary Disease (Coronary Heart Disease) 12/2012
1	Dyslipidemias (Dyslipidemia) 12/2012
1	Cardiovascular Diseases (Cardiovascular Disease) 12/2012
1	Ductal Carcinoma 06/2011

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 01/2020 - 08/2010
3	LigandsIBA 01/2018 - 06/2011
2	RNA (Ribonucleic Acid)IBA 11/2020 - 01/2020
2	Basic Helix-Loop-Helix Transcription FactorsIBA 01/2020 - 05/2014
2	Tyrosine (L-Tyrosine)FDA Link 09/2014 - 11/2010
2	ErbB Receptors (EGF Receptor)IBA 09/2014 - 11/2010
1	Prescription DrugsIBA 01/2021
1	Insulin (Novolin)FDA Link 07/2020
1	Small Interfering RNA (siRNA)IBA 01/2020
1	Inhibitor of Differentiation Protein 1IBA 01/2020
1	Latanoprost (Xalatan)FDA Link 09/2019
1	Bimatoprost (Lumigan)FDA Link 09/2019
1	Travoprost (Travatan)FDA Link 09/2019
1	Synthetic Prostaglandins (Prostaglandin Analogues)IBA 09/2019
1	Antirheumatic Agents (DMARD)IBA 08/2019
1	Serum AlbuminIBA 11/2018
1	Fibrillar CollagensIBA 01/2018
1	Docetaxel (Taxotere)FDA Link 01/2018
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 06/2017
1	MicroRNAs (MicroRNA)IBA 06/2015
1	ClaudinsIBA 09/2014
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 09/2014
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 09/2014
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 09/2014
1	Inhibitor of Differentiation ProteinsIBA 05/2014
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 05/2014
1	HhAntag691IBA 03/2013
1	InterferonsIBA 01/2013
1	CarcinogensIBA 01/2013
1	Interleukin-27 (Interleukin 27)IBA 01/2013
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2012
1	LipidsIBA 12/2012
1	Monoclonal AntibodiesIBA 06/2011
1	src-Family KinasesIBA 11/2010
1	Phosphotransferases (Kinase)IBA 11/2010
1	Phenobarbital (Luminal)FDA Link 11/2010
1	Pharmaceutical PreparationsIBA 11/2010

Therapy/Procedure

9	Therapeutics 01/2022 - 11/2010
2	Duration of Therapy 09/2019 - 06/2017
1	Secondary Prevention 01/2022
1	Thrombectomy 01/2022